VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses

Journal of Experimental Medicine

Volumn 208, Issue 3, 2011, Pages 577-592

  Wang, Li ^a   Rubinstein, Rotem ^d   Lines, Janet L ^a   Wasiuk, Anna ^a   Ahonen, Cory ^a   Guo, Yanxia ^a   Lu, Li Fan ^a   Gondek, David ^a   Wang, Yan ^a   Fava, Roy A ^c   Fiser, Andras ^d   Almo, Steve ^d   Noelle, Randolph J ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c VA MEDICAL CENTER   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 DOMAIN IG SUPPRESSOR OF T CELL ACTIVATION; HYBRID PROTEIN; IMMUNOMODULATING AGENT; LIGAND; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEMATOPOIETIC CELL; IMMUNITY; IMMUNOSURVEILLANCE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOGLOBULINS; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 79952717517     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100619     Document Type: Article

References (59)

1. Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Ansari, M.J., A.D. Salama, T. Chitnis, R.N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S.J. Khoury, et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:63-69. doi:10.1084/jem.20022125 (Pubitemid 36870186)
3. Atkinson, H.J., J.H. Morris, T.E. Ferrin, and P.C. Babbitt. 2009. Using sequence similarity networks for visualization of relationships across diverse protein superfamilies. PLoS ONE. 4:e4345. doi:10.1371/journal.pone.0004345
4. Berman, H.M., J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-242. doi:10.1093/nar/28.1.235 (Pubitemid 30047768)
5. Blank, C., I. Brown, A.C. Peterson, M. Spiotto, Y. Iwai, T. Honjo, and T.F. Gajewski. 2004. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res. 64:1140-1145. doi:10.1158/0008-5472.CAN-03-3259 (Pubitemid 38176921)
6. Blank, C., T.F. Gajewski, and A. Mackensen. 2005. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol. Immunother. 54:307-314. doi:10.1007/s00262-004-0593-x (Pubitemid 40238924)
7. Borriello, F., M.P. Sethna, S.D. Boyd, A.N. Schweitzer, E.A. Tivol, D. Jacoby, T.B. Strom, E.M. Simpson, G.J. Freeman, and A.H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity. 6:303-313. doi:10.1016/S1074-7613(00)80333- 7
8. Brandt, C.S., M. Baratin, E.C. Yi, J. Kennedy, Z. Gao, B. Fox, B. Haldeman, C.D. Ostrander, T. Kaifu, C. Chabannon, et al. 2009. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206:1495-1503. doi:10.1084/jem.20090681
9. Breithaupt, C., A. Schubart, H. Zander, A. Skerra, R. Huber, C. Linington, and U. Jacob. 2003. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc. Natl. Acad. Sci. USA. 100:9446-9451. doi:10.1073/pnas.1133443100 (Pubitemid 37033948)
10. Butte, M.J., M.E. Keir, T.B. Phamduy, A.H. Sharpe, and G.J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 27:111-122. doi:10.1016/j.immuni.2007.05.016 (Pubitemid 47089023)
11. Carter, L., L.A. Fouser, J. Jussif, L. Fitz, B. Deng, C.R. Wood, M. Collins, T. Honjo, G.J. Freeman, and B.M. Carreno. 2002. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32:634-643. doi:10.1002/1521-4141(200203)32:3〈634::AID- IMMU634〉3.0.CO;2-9 (Pubitemid 34257540)
12. Chambers, C.A., T.J. Sullivan, and J.P. Allison. 1997. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation- dependent activation of CD4+ T cells. Immunity. 7:885-895. doi:10.1016/S1074- 7613(00)80406-9
13. Dong, C., A.E. Juedes, U.A. Temann, S. Shresta, J.P. Allison, N.H. Ruddle, and R.A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature. 409:97-101. doi:10.1038/35051100 (Pubitemid 32098632)
14. Dong, H., and L. Chen. 2003. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 81:281-287. (Pubitemid 36718324)
15. Dong, H., S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, P.C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8:793-800.
16. Flicek, P., B.L. Aken, K. Beal, B. Ballester, M. Caccamo, Y. Chen, L. Clarke, G. Coates, F. Cunningham, T. Cutts, et al. 2008. Ensembl 2008. Nucleic Acids Res. 36:D707-D714. doi:10.1093/nar/gkm988 (Pubitemid 351149811)
17. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341. doi:10.1016/j.immuni.2005.01. 016 (Pubitemid 40387475)
18. Geng, H., G.M. Zhang, H. Xiao, Y. Yuan, D. Li, H. Zhang, H. Qiu, Y.F. He, and Z.H. Feng. 2006. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma. Int. J. Cancer. 118:2657-2664. doi:10.1002/ijc.21795 (Pubitemid 43673341)
19. Gouet, P., E. Courcelle, D.I. Stuart, and F. Métoz. 1999. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics. 15:305-308. doi:10.1093/bioinformatics/15.4.305 (Pubitemid 29213756)
20. Grabie, N., I. Gotsman, R. DaCosta, H. Pang, G. Stavrakis, M.J. Butte, M.E. Keir, G.J. Freeman, A.H. Sharpe, and A.H. Lichtman. 2007. Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. Circulation. 116:2062-2071. doi:10.1161/CIRCULATIONAHA.107.709360
21. Greenwald, R.J., G.J. Freeman, and A.H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23:515-548. doi:10.1146/annurev.immunol.23. 021704.115611
22. Guleria, I., A. Khosroshahi, M.J. Ansari, A. Habicht, M. Azuma, H. Yagita, R.J. Noelle, A. Coyle, A.L. Mellor, S.J. Khoury, and M.H. Sayegh. 2005. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 202:231-237. doi:10.1084/jem.20050019 (Pubitemid 41043819)
23. Hernández Prada, J.A., R.N. Haire, M. Allaire, J. Jakoncic, V. Stojanoff, J.P. Cannon, G.W. Litman, and D.A. Ostrov. 2006. Ancient evolutionary origin of diversified variable regions demonstrated by crystal structures of an immune-type receptor in amphioxus. Nat. Immunol. 7:875-882. doi:10.1038/ni1359
24. Hollenbaugh, D., J. Douthwright, V. McDonald, and A. Aruffo. 1995. Cleavable CD40Ig fusion proteins and the binding to sgp39. J. Immunol. Methods. 188:1-7. doi:10.1016/0022-1759(95)00194-8
25. Holm, L., and J. Park. 2000. DaliLite workbench for protein structure comparison. Bioinformatics. 16:566-567. doi:10.1093/bioinformatics/16.6.566
26. Iwai, Y., M. Ishida, Y. Tanaka, T. Okazaki, T. Honjo, and N. Minato. 2002. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA. 99:12293-12297. doi:10.1073/pnas.192461099
27. Keir, M.E., S.C. Liang, I. Guleria, Y.E. Latchman, A. Qipo, L.A. Albacker, M. Koulmanda, G.J. Freeman, M.H. Sayegh, and A.H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203:883-895. doi:10.1084/jem.20051776
28. Keir, M.E., G.J. Freeman, and A.H. Sharpe. 2007. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues. J. Immunol. 179:5064-5070.
29. Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704. doi:10.1146/annurev.immunol.26.021607.090331
30. Larkin, M.A., G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, H. McWilliam, F. Valentin, I.M. Wallace, A. Wilm, R. Lopez, et al. 2007. Clustal W and Clustal X version 2.0. Bioinformatics. 23:2947-2948. doi:10.1093/ bioinformatics/btm404
31. Latchman, Y.E., S.C. Liang, Y. Wu, T. Chernova, R.A. Sobel, M. Klemm, V.K. Kuchroo, G.J. Freeman, and A.H. Sharpe. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA. 101:10691-10696. doi:10.1073/pnas.0307252101
32. Lázár-Molnár, E., Q. Yan, E. Cao, U. Ramagopal, S.G. Nathenson, and S.C. Almo. 2008. Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2. Proc. Natl. Acad. Sci. USA. 105:10483-10488. doi:10.1073/pnas.0804453105
33. Liang, S.C., Y.E. Latchman, J.E. Buhlmann, M.F. Tomczak, B.H. Horwitz, G.J. Freeman, and A.H. Sharpe. 2003. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33:2706-2716. doi:10.1002/eji.200324228
34. Lin, D.Y., Y. Tanaka, M. Iwasaki, A.G. Gittis, H.P. Su, B. Mikami, T. Okazaki, T. Honjo, N. Minato, and D.N. Garboczi. 2008. The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc. Natl. Acad. Sci. USA. 105:3011-3016. doi:10.1073/pnas.0712278105
35. Lobley, A., M.I. Sadowski, and D.T. Jones. 2009. pGenTHREADER and pDomTHREADER: new methods for improved protein fold recognition and superfamily discrimination. Bioinformatics. 25:1761-1767. doi:10.1093/bioinformatics/btp302
36. Lutz, M.B., N. Kukutsch, A.L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92. doi:10.1016/S0022-1759(98)00204-X
37. Mackey, M.F., J.R. Gunn, P.P. Ting, H. Kikutani, G. Dranoff, R.J. Noelle, and R.J. Barth Jr. 1997. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Cancer Res. 57:2569-2574.
38. McIvor, R.S., and C.C. Simonsen. 1990. Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells. Nucleic Acids Res. 18:7025-7032. doi:10.1093/nar/18.23.7025
39. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 11:141-151. doi:10.1016/S1074-7613(00)80089-8
40. Nishimura, H., T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hiai, N. Minato, and T. Honjo. 2001. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 291:319-322. doi:10.1126/science.291.5502.319
41. Okazaki, T., and T. Honjo. 2006. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 27:195-201. doi:10.1016/j.it.2006.02.001
42. Rai, B.K., and A. Fiser. 2006. Multiple mapping method: a novel approach to the sequence-to-structure alignment problem in comparative protein structure modeling. Proteins. 63:644-661. doi:10.1002/prot.20835
43. Rai, B.K., C.J. Madrid-Aliste, J.E. Fajardo, and A. Fiser. 2006. MMM: a sequence-to-structure alignment protocol. Bioinformatics. 22:2691-2692. doi:10.1093/bioinformatics/btl449
44. Salama, A.D., T. Chitnis, J. Imitola, M.J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M.H. Sayegh, and S.J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198:71-78. doi:10.1084/jem.20022119
45. Shannon, P., A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T. Ideker. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498-2504. doi:10.1101/gr.1239303
46. Shulman, M., C.D. Wilde, and G. Köhler. 1978. A better cell line for making hybridomas secreting specific antibodies. Nature. 276:269-270. doi:10.1038/276269a0
47. Sica, G.L., I.H. Choi, G. Zhu, K. Tamada, S.D. Wang, H. Tamura, A.I. Chapoval, D.B. Flies, J. Bajorath, and L. Chen. 2003. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 18:849-861. doi:10.1016/S1074-7613(03)00152-3
48. Son, Y.I., S. Egawa, T. Tatsumi, R.E. Redlinger Jr., P. Kalinski, and T. Kanto. 2002. A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J. Immunol. Methods. 262:145-157. doi:10.1016/S0022-1759(02)00013-3
49. Stromnes, I.M., and J.M. Goverman. 2006a. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1:1810-1819. doi:10.1038/nprot.2006.285
50. Stromnes, I.M., and J.M. Goverman. 2006b. Passive induction of experimental allergic encephalomyelitis. Nat. Protoc. 1:1952-1960. doi:10.1038/nprot.2006.284
51. Su, A.I., M.P. Cooke, K.A. Ching, Y. Hakak, J.R. Walker, T. Wiltshire, A.P. Orth, R.G. Vega, L.M. Sapinoso, A. Moqrich, et al. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. USA. 99:4465-4470. doi:10.1073/pnas.012025199
52. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547. doi:10.1016/1074-7613(95)90125-6
53. van Raaij, M.J., E. Chouin, H. van der Zandt, J.M. Bergelson, and S. Cusack. 2000. Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution. Structure. 8:1147-1155. doi:10.1016/S0969-2126(00) 00528-1
54. Wang, L., K. Pino-Lagos, V.C. de Vries, I. Guleria, M.H. Sayegh, and R.J. Noelle. 2008. Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 105:9331-9336. doi:10.1073/pnas.0710441105
55. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985-988. doi:10.1126/science.270.5238.985
56. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D.M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169:5538-5545.
57. Yoshinaga, S.K., J.S. Whoriskey, S.D. Khare, U. Sarmiento, J. Guo, T. Horan, G. Shih, M. Zhang, M.A. Coccia, T. Kohno, et al. 1999. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 402:827-832. doi:10.1038/45582
58. Zhang, X., and R. Ren. 1998. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocytemacrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood. 92:3829-3840.
59. Zou, W., and L. Chen. 2008. Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8:467-477. doi:10.1038/nri2326